Home / Stocks / MLYS

MLYS insider trading

Mineralys Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$91.0M
Buys · last 90 days
0 · $0
Most recent buy
2026-03-31

Cluster buy detected

4 insiders bought MLYS within a short window (2025-03-13), $37.2M in total — cluster score 43/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-06-30Warren Eric
Chief Commercial Officer
Sold104,124$25.90$2.7M
2026-06-30Congleton Jon
Chief Executive Officer
Sold58,000$25.94$1.5M
2026-04-02Congleton Jon
Chief Executive Officer
Sold55,183$26.54$1.5M
2026-03-31Kolchinsky Peter
Director
Bought369,000$23.75$8.8M
2026-01-06Rodman David Malcom
Chief Medical Officer
Sold262,752$35.25$9.3M
2025-11-21Slingsby Brian Taylor
Director · 10% owner
Sold1,000,000$43.35$43.4M
2025-11-13Levy Adam Scott
CFO and Secretary
Sold71,618$46.36$3.3M
2025-11-13Congleton Jon
Chief Executive Officer
Sold174,332$45.92$8.0M
2025-09-08AKKARAJU SRINIVAS
Director
Bought588,235$25.50$15.0M
2025-09-08Kolchinsky Peter
Director
Bought1,176,470$25.50$30.0M
2025-04-25Slingsby Brian Taylorcluster
Director · 10% owner
Bought259,259$13.50$3.5M
2025-03-17Samsara BioCapital GP, LLCcluster
10% owner
Bought600,000$13.50$8.1M
2025-03-17AKKARAJU SRINIVAScluster
Director
Bought600,000$13.50$8.1M
2025-03-17Kolchinsky Petercluster
Director
Bought1,296,296$13.50$17.5M

Most active insider buyers

InsiderRoleBuysTotal bought
Kolchinsky PeterDirector3$56.3M
AKKARAJU SRINIVASDirector2$23.1M
Samsara BioCapital GP, LLC10% owner1$8.1M
Slingsby Brian TaylorDirector · 10% owner1$3.5M

See MLYS on the chart

Every insider buy and sell for MLYS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.